Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Cardiovascular pharmacogenomics].

Ugeskrift for laeger - 20 Apr 2009

Ahlehoff Ole, Hansen Peter Riis

Abstract excerpt

The past few years have witnessed considerable advances in the field of cardiovascular pharmacogenomics, not least as a result of genome-wide surveys. We here briefly review recent advances supporting the value of genetic information in the treatment of patients with betablockers, statins and warfarin. Although definitive proof that genotyping can change outcomes of patients with cardiovascular diseases await...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Anticholesteremic Agents
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Cytochrome P-450 Enzyme System

Share to Pharmacogenetics

Share to Treatment Outcome

Share to Warfarin

Source

Identifiers

PMID: 19413939

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Cardiovascular pharmacogenomics].PMID 19413939Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

Pharmacogenomics in cardiac therapy: Personalizing treatment for heart healthSemantic proximity Read ↗

Pharmacogenomics--10 years of progress: a cardiovascular perspective.Semantic proximity Read ↗

Pharmacogenomics in cardiovascular diseases.Semantic proximity Read ↗

Cardiovascular pharmacogenomics.Semantic proximity Read ↗

Cardiovascular pharmacogenomics: current status and future directions.Semantic proximity Read ↗

[Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].Semantic proximity Read ↗

Expanding Role of Pharmacogenomics in the Management of Cardiovascular DisordersSemantic proximity Read ↗

Pharmacogenomics in Cardiovascular Diseases.Semantic proximity Read ↗

Genomics of cardiovascular disease.Semantic proximity Read ↗

Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Semantic proximity Read ↗

Pharmacogenomics and management of cardiovascular disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.